Neurocognitive Effects and Tolerability of Efavirenz in Aging HIV-infected Individuals ("SHAC Neuro Study")

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2015 by Stanford University
Sponsor:
Collaborator:
Janssen Services, LLC
Information provided by (Responsible Party):
Philip Grant, Stanford University
ClinicalTrials.gov Identifier:
NCT01985399
First received: November 4, 2013
Last updated: May 26, 2015
Last verified: May 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)